Literature DB >> 1350746

5-Methylurapidil may discriminate between alpha 1-adrenoceptors with a high affinity for WB4101 in rat lung.

Y Hiramatsu1, R Muraoka, S Kigoshi, I Muramatsu.   

Abstract

The alpha 1-adrenoceptors of rat lung with a high affinity for [3H]-prazosin were subdivided into two populations (high and low affinity sites) by WB4101 and 5-methylurapidil but the proportions were different between both drugs. After pretreatment with chlorethylclonidine, WB4101 recognized only high affinity sites, while 5-methylurapidil still detected high and low affinity sites. These results indicate that alpha 1-adrenoceptors with a high affinity for WB4101 are not homogeneous in the rat lung, suggesting the possible existence of a new alpha 1-adrenoceptor subtype in addition to alpha 1A and alpha 1B subtypes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350746      PMCID: PMC1908623          DOI: 10.1111/j.1476-5381.1992.tb14200.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype.

Authors:  D A Schwinn; J W Lomasney; W Lorenz; P J Szklut; R T Fremeau; T L Yang-Feng; M G Caron; R J Lefkowitz; S Cotecchia
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

Review 2.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

3.  Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.

Authors:  A L Morrow; I Creese
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

4.  Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.

Authors:  G Hanft; G Gross
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

5.  Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5.

Authors:  J W Lomasney; S Cotecchia; W Lorenz; W Y Leung; D A Schwinn; T L Yang-Feng; M Brownstein; R J Lefkowitz; M G Caron
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

  5 in total
  7 in total

1.  Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.

Authors:  R Bültmann; A K Kurz; K Starke
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

2.  Identification of alpha 1-adrenoceptor subtypes in the dog prostate.

Authors:  T Ohmura; S Sakamoto; H Hayashi; S Kigoshi; I Muramatsu
Journal:  Urol Res       Date:  1993-05

3.  Alpha 1-adrenoceptors in the human prostatic urethra are different from those of the human peripheral arteries.

Authors:  M Takeda; A Hatano; H Takahashi; M Tamaki; T Komeyama; T Koizumi; T Tsutsui
Journal:  Clin Investig       Date:  1993-12

4.  Pharmacological characterization of two distinct alpha 1-adrenoceptor subtypes in rabbit thoracic aorta.

Authors:  M Oshita; S Kigoshi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

5.  Comparison of cloned and pharmacologically defined rat tissue alpha 1-adrenoceptor subtypes.

Authors:  M C Michel; P A Insel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

6.  Alpha 1-adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal alpha 1-adrenoceptor.

Authors:  M C Michel; R Büscher; J Kerker; H Kraneis; W Erdbrügger; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

7.  Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Authors:  D R Blue; D W Bonhaus; A P Ford; J R Pfister; N A Sharif; I A Shieh; R L Vimont; T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.